Recently, while contemplating the AAPA-AMA scope creep debate, I encountered a quote about GLP1-RAs for obesity: “We need to just really think about it as a chronic disease … to make sure that we try to keep that patient in [ongoing] treatm…
Category: Meds
Antipsychotic use has been rising in long-term care homes, but we can do something about it
As health care providers working in long-term care (LTC), we’ve seen firsthand how antipsychotic medications are prescribed to residents, and why. Antipsychotics are often used to help manage behaviors such as agitation and aggression in older ad…
Antipsychotic use has been rising in long-term care homes, but we can do something about it
As health care providers working in long-term care (LTC), we’ve seen firsthand how antipsychotic medications are prescribed to residents, and why. Antipsychotics are often used to help manage behaviors such as agitation and aggression in older ad…
The miracle of immune checkpoint inhibitors: a physician’s unforgettable journey
Even a half-century later, a physician cannot forget the first death of a patient under their care. It happened for me during my postgraduate medical training in the 1970s in an academic medical center hospital in the western half of the United States….
The miracle of immune checkpoint inhibitors: a physician’s unforgettable journey
Even a half-century later, a physician cannot forget the first death of a patient under their care. It happened for me during my postgraduate medical training in the 1970s in an academic medical center hospital in the western half of the United States….
You could soon be taking (or prescribing) a drug developed by AI
Across all industries, artificial intelligence is changing our approach to developing new products, including in the life sciences and drug development. While it may seem that an AI-derived treatment is far in the future, the science, biomathematics, a…
The testosterone surge: Are men chasing solutions or creating new risks?
Among men, even before COVID-19, the popularity of testosterone therapy since 2000 likely outpaced the clinical need. There have been a number of proposed reasons for this, such as increased direct-to-consumer marketing for low testosterone treatments …
Navigating patient transitions following the withdrawal of Oxbryta
The withdrawal of Oxbryta (voxelotor) from global markets, announced by Pfizer after a recent data review revealed a rise in deaths and complications, has left sickle cell disease (SCD) patients in a precarious situation. The sudden nature of the annou…
Are you taking FDA-approved drugs without knowing it?
If you think the labyrinth of U.S. government agencies and congressional subcommittees is complicated, be grateful you are not a pharmacy owner! Just to get your drugs reimbursed, you must navigate a river of upstream, midstream, and downstream supplie…
The hidden medication putting Parkinson’s patients at risk
At the doctor’s office, in the ER, in the hospital, how many times are you asked about your drug allergies? A lot! And, as a common practice when in the hospital, you’ll even get a red bracelet or something to indicate such. There are stric…
